G&S Capital LLC Abb Vie Inc. Transaction History

G&S Capital LLC

$229 Million
Q3 2024

A detailed history of G&S Capital LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, G&S Capital LLC holds 5,783 shares of ABBV stock, worth $985,134. This represents 0.5% of its overall portfolio holdings.

Number of Shares

5,783

Previous 5,731 0.91%

Holding current value

$985,134

Previous $982,000 16.29%

% of portfolio

0.5%

Previous 0.42%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 16, 2024	BUY	$163.84 - $199.33 $8,519 - $10,365	52 Added 0.91%	5,783 $1.14 Million
Q2 2024 Jul 30, 2024	SELL	$154.79 - $180.76 $16,562 - $19,341	-107 Reduced 1.83%	5,731 $982,000
Q1 2024 Apr 15, 2024	SELL	$159.82 - $182.1 $13,105 - $14,932	-82 Reduced 1.39%	5,838 $1.06 Million
Q4 2023 Jan 26, 2024	BUY	$137.6 - $154.97 $18,576 - $20,920	135 Added 2.33%	5,920 $917,000
Q3 2023 Oct 12, 2023	BUY	$133.59 - $154.65 $8,950 - $10,361	67 Added 1.17%	5,785 $862,000
Q2 2023 Jul 26, 2023	SELL	$132.51 - $164.9 $338,430 - $421,154	-2,554 Reduced 30.88%	5,718 $770,000
Q1 2023 Apr 20, 2023	BUY	$144.61 - $166.54 $459,136 - $528,764	3,175 Added 62.29%	8,272 $1.32 Million
Q4 2022 Jan 20, 2023	BUY	$138.31 - $165.87 $68,463 - $82,105	495 Added 10.76%	5,097 $0
Q3 2022 Oct 21, 2022	BUY	$134.21 - $153.93 $43,886 - $50,335	327 Added 7.65%	4,602 $618,000
Q2 2022 Jul 21, 2022	BUY	$137.62 - $174.96 $30,689 - $39,016	223 Added 5.5%	4,275 $655,000
Q1 2022 Apr 15, 2022	SELL	$131.98 - $163.75 $9,106 - $11,298	-69 Reduced 1.67%	4,052 $657,000
Q4 2021 Jan 20, 2022	BUY	$107.43 - $135.93 $23,527 - $29,768	219 Added 5.61%	4,121 $558,000
Q3 2021 Oct 19, 2021	BUY	$106.4 - $120.78 $36,920 - $41,910	347 Added 9.76%	3,902 $421,000
Q2 2021 Jul 22, 2021	BUY	$105.21 - $117.21 $39,032 - $43,484	371 Added 11.65%	3,555 $400,000
Q1 2021 Apr 15, 2021	BUY	$102.3 - $112.62 $31,815 - $35,024	311 Added 10.82%	3,184 $345,000
Q4 2020 Jan 21, 2021	BUY	$80.49 - $108.67 $2,575 - $3,477	32 Added 1.13%	2,873 $308,000
Q3 2020 Oct 21, 2020	BUY	$85.91 - $100.83 $11,426 - $13,410	133 Added 4.91%	2,841 $249,000
Q2 2020 Jul 24, 2020	SELL	$73.37 - $98.18 $20,396 - $27,294	-278 Reduced 9.31%	2,708 $266,000
Q1 2020 Apr 23, 2020	BUY	$64.5 - $97.79 $2,451 - $3,716	38 Added 1.29%	2,986 $227,000
Q4 2019 Jan 21, 2020	BUY	$72.13 - $90.25 $9,593 - $12,003	133 Added 4.72%	2,948 $261,000
Q3 2019 Oct 17, 2019	BUY	$62.98 - $75.72 $19,271 - $23,170	306 Added 12.2%	2,815 $213,000
Q2 2019 Jul 19, 2019	SELL	$65.7 - $83.98 $16,359 - $20,911	-249 Reduced 9.03%	2,509 $182,000
Q1 2019 Apr 22, 2019	BUY	$77.14 - $90.79 $94,805 - $111,580	1,229 Added 80.38%	2,758 $222,000
Q4 2018 Jan 15, 2019	SELL	$77.85 - $96.01 $2.77 Million - $3.42 Million	-35,574 Reduced 95.88%	1,529 $141,000
Q3 2018 Oct 30, 2018	BUY	$88.91 - $98.84 $3.19 Million - $3.55 Million	35,892 Added 2963.83%	37,103 $3.51 Million
Q2 2018 Aug 01, 2018	BUY	$89.78 - $106.23 $11,491 - $13,597	128 Added 11.82%	1,211 $112,000
Q1 2018 Apr 25, 2018	BUY	$92.01 - $123.21 $26,406 - $35,361	287 Added 36.06%	1,083 $102,000
Q4 2017 Feb 14, 2018	BUY	$89.56 - $98.21 $71,289 - $78,175	796	796 $77,000

Others Institutions Holding ABBV

# of Institutions

3,817

Shares Held

1.25B

Call Options Held

13M

Put Options Held

10M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $301B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of G&S Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on G&S Capital LLC with notifications on news.

Account